Correlation Between Larimar Therapeutics and Bolt Biotherapeutics

Can any of the company-specific risk be diversified away by investing in both Larimar Therapeutics and Bolt Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Larimar Therapeutics and Bolt Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Larimar Therapeutics and Bolt Biotherapeutics, you can compare the effects of market volatilities on Larimar Therapeutics and Bolt Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Larimar Therapeutics with a short position of Bolt Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Larimar Therapeutics and Bolt Biotherapeutics.

Diversification Opportunities for Larimar Therapeutics and Bolt Biotherapeutics

0.83

Correlation Coefficient

Larimar Therapeutics  Bolt Biotherapeutics

Very poor diversification

The 3 months correlation between Larimar and Bolt is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Larimar Therapeutics and Bolt Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bolt Biotherapeutics and Larimar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Larimar Therapeutics are associated (or correlated) with Bolt Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bolt Biotherapeutics has no effect on the direction of Larimar Therapeutics i.e., Larimar Therapeutics and Bolt Biotherapeutics go up and down completely randomly.

Pair Corralation between Larimar Therapeutics and Bolt Biotherapeutics

Given the investment horizon of 90 days Larimar Therapeutics is expected to under-perform the Bolt Biotherapeutics. In addition to that, Larimar Therapeutics is 1.42 times more volatile than Bolt Biotherapeutics. It trades about -0.15 of its total potential returns per unit of risk. Bolt Biotherapeutics is currently generating about -0.11 per unit of volatility. If you would invest  57.00  in Bolt Biotherapeutics on December 28, 2024 and sell it today you would lose (13.00) from holding Bolt Biotherapeutics or give up 22.81% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Larimar Therapeutics  vs.  Bolt Biotherapeutics

Larimar Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Larimar Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's primary indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Bolt Biotherapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bolt Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Larimar Therapeutics and Bolt Biotherapeutics

The main advantage of trading using opposite Larimar Therapeutics and Bolt Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Larimar Therapeutics position performs unexpectedly, Bolt Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bolt Biotherapeutics will offset losses from the drop in Bolt Biotherapeutics' long position.

The idea behind Larimar Therapeutics and Bolt Biotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.